Future studies should investigate the EV-based method as an adjunct to the standard procedures, assessing its diagnostic performance in the large prospective cohort and evaluating its clinical impact on the early treatment initiation in patients with MYCN-amplified high-risk neuroblastoma. Here, MYCN is linked to neuroblastoma.